HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer

Hepatoma-derived growth factor (HDGF) expression is associated with poor prognosis in non-small cell lung cancer (NSCLC); however, whether HDGF affects gefitinib resistance in NSCLC remains unknown. This study aimed to explore the role of HDGF in gefitinib resistance in NSCLC and to discover the und...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Shuyan, Tian, Zhihua, Tian, Huifang, Han, Haibo, Zhao, Jun, Jiao, Yanna, Wang, Chunli, Hao, Huifeng, Wang, Shan, Fu, Jialei, Xue, Dong, Sun, Hong, Li, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257651/
https://www.ncbi.nlm.nih.gov/pubmed/37301856
http://dx.doi.org/10.1038/s41420-023-01476-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257651/
https://www.ncbi.nlm.nih.gov/pubmed/37301856
http://dx.doi.org/10.1038/s41420-023-01476-0

Ejemplares similares